TYPE1DIABETES
Clinical trials for TYPE1DIABETES explained in plain language.
Never miss a new study
Get alerted when new TYPE1DIABETES trials appear
Sign up with your email to follow new studies for TYPE1DIABETES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a common T2D drug stop ketoacidosis risk in type 1 diabetes?
Disease control Not yet recruitingThis study looks at whether adding pioglitazone (a type 2 diabetes drug) to dapagliflozin (an SGLT2 inhibitor) can reduce the liver's glucose production, fat breakdown, and ketone production in people with type 1 diabetes. These effects from dapagliflozin can raise the risk of ke…
Matched conditions: TYPE1DIABETES
Phase: PHASE3 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 08, 2026 13:04 UTC
-
New study asks: is this glucose monitor a Game-Changer for diabetes?
Knowledge-focused Not yet recruitingThis study will ask 75 people with diabetes and their healthcare providers about their experience using the Instara-1 continuous glucose monitor. Participants will wear the device and answer questionnaires about comfort, ease of use, and how it helps manage their diabetes. The go…
Matched conditions: TYPE1DIABETES
Sponsor: Getz Pharma • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:48 UTC
-
Diet drinks under scrutiny: new study eyes heart risks in young diabetics
Knowledge-focused Not yet recruitingThis study looks at how non-nutritive sweeteners (like those in diet drinks) affect the heart and blood vessels of young adults with type 1 diabetes. Researchers will measure blood vessel function before and after drinking a sweetened sports drink. The goal is to understand if th…
Matched conditions: TYPE1DIABETES
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:07 UTC